Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome.
Cristina Valencia SanchezAndrew M KnightMohammad Bakri HammamiYong GuoJohn R MillsThomas J KryzerAmanda L PiquetAnik AminMorgan HeinzelmannClaudia F LucchinettiVanda A LennonAndrew McKeonSean J PittockDivyanshu DubeyPublished in: Journal of neurology, neurosurgery, and psychiatry (2021)
This study supports TRIM46-IgG being a biomarker of paraneoplastic CNS disorders and expands the neurological phenotypes, oncological and ICI-related adverse event associations.